CiiTECH is a cannabis biotech company that focuses on discovering, developing and commercializing cannabis products for wellness markets.
CiiTECH has partnered with the leading Israeli academics, institutions and organisations for innovative cannabinoid research.
Designed & developed in Israel, made in the UK & EU to ensure 100% legal CBD products from our global distribution HQ in UK.
Developed and designed brands from key opinion leaders and institutions. PROVACAN
CiiTECH selected the Hebrew University of Jerusalem as our strategic research partner. This gold-label institution has the richest history of cannabis breakthroughs and cannabinoid therapy patents in the world.
Our initial study in partnership with Professor Raphael Mechoulam and Professor Francesca Levi-Shaffer is investigating the potential for a CBD derivative to be an effective treatment for asthma.
We’re currently funding a range of clinical studies aimed at unraveling the vast range of minor cannabinoids, bringing better understanding and more effective products to market.CiiTECH RESEARCH STUDIES